ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748,454 | -28.7% | 918,349 | -19.2% | 0.06% | -36.6% |
| Q2 2023 | $1,049,367 | +15.0% | 1,136,416 | -5.5% | 0.10% | +44.3% |
| Q1 2023 | $912,571 | -70.3% | 1,203,126 | -1.9% | 0.07% | -64.8% |
| Q4 2022 | $3,077,739 | +217.9% | 1,226,191 | +76.0% | 0.20% | +215.9% |
| Q3 2022 | $968,000 | +3.6% | 696,538 | -6.0% | 0.06% | +34.0% |
| Q2 2022 | $934,000 | -58.6% | 741,010 | -4.7% | 0.05% | -53.0% |
| Q1 2022 | $2,256,000 | +9.8% | 777,820 | -13.7% | 0.10% | +38.9% |
| Q4 2021 | $2,055,000 | -12.2% | 901,290 | -1.4% | 0.07% | -2.7% |
| Q3 2021 | $2,340,000 | -12.5% | 914,197 | -2.2% | 0.07% | -2.6% |
| Q2 2021 | $2,673,000 | -8.0% | 934,755 | 0.0% | 0.08% | -10.6% |
| Q1 2021 | $2,907,000 | +12.1% | 934,755 | -5.6% | 0.08% | +6.2% |
| Q4 2020 | $2,593,000 | -9.1% | 989,755 | -0.1% | 0.08% | -8.0% |
| Q3 2020 | $2,853,000 | -16.0% | 990,655 | 0.0% | 0.09% | -14.7% |
| Q2 2020 | $3,398,000 | +72.4% | 990,655 | 0.0% | 0.10% | +37.8% |
| Q1 2020 | $1,971,000 | -50.4% | 990,655 | 0.0% | 0.07% | -39.3% |
| Q4 2019 | $3,973,000 | +25.7% | 990,655 | 0.0% | 0.12% | +4.3% |
| Q3 2019 | $3,160,000 | -18.2% | 990,655 | 0.0% | 0.12% | -1.7% |
| Q2 2019 | $3,864,000 | -82.0% | 990,655 | +12.0% | 0.12% | -82.2% |
| Q1 2019 | $21,492,000 | +18.2% | 884,455 | -2.1% | 0.67% | +19.9% |
| Q4 2018 | $18,178,000 | -14.7% | 903,455 | +30.7% | 0.56% | -2.6% |
| Q3 2018 | $21,322,000 | +294.5% | 691,388 | +176.3% | 0.57% | +162.1% |
| Q2 2018 | $5,405,000 | +12.1% | 250,252 | 0.0% | 0.22% | +0.9% |
| Q1 2018 | $4,822,000 | – | 250,252 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|